- Detail & Program Access
- Overview & Objectives
- Credit Eligibility
- Program Materials
- Funding Support
View Session 2
View Session 3
Program Access and Details:
90 minutes x 3
DOWNLOADABLE SLIDES. View the Program Materials tab for more information.
The OnDemand version of this program is not accredited. Physicians may earn self-learning credits through active steps. View more information under the Credit Eligibility tab.
Family physicians, cardiovascular specialists, allied health professionals
SESSION 1 - LEARNING OBJECTIVES
- Explore current role of GLP-1 agonists in clinical practice
- Recognize the impact of kidney protection for cardiac protection
- Determine when to use medical vs surgical treatment in stable CAD
- Describe appropriate antiplatelet therapy for stable CAD patients
SESSION 2 - LEARNING OBJECTIVES
- Describe a guidelines centric approach to manage and support patients with obesity
- Distinguish the appropriate use of ezetimibe or PCSK9 inhibitors in secondary prevention
- Discuss the role of a new market entrance in lipid management
- Apply guideline centric strategies for managing cardiovascular risk beyond LDL-C
SESSION 3 - LEARNING OBJECTIVES
- Summarize the benefits and challenges with using DOAC’s
- Describe appropriate management strategies and therapies for managing patients with HFrEF and HFpEF
- Explore developments in cardiovascular medicine that may change how we treat patients in the future
The OnDemand recordings of this live program are NOT accredited.
Mainpro+ participants may earn certified credits by completing a Linking Learning Exercise.
Specialist participants may claim Section 2 credits (up to 2 credits per hour) following completion of a personal learning project (PLP) under Section 2: Self-Learning Activities within the MAINPORT ePortfolio.
This program has been developed by the Canadian Collaborative Research Network, a not-for-profit physician organization, and was supported through an educational grant received from Gold: HLS Therapeutics; Silver: AstraZeneca, Bayer, BMS/Pfizer Alliance, Boehringer Ingelheim, Janssen, KYE Pharmaceuticals, Sanofi and in-kind support from Pfizer.
This program was developed by the Canadian Collaborative Research Network, a not-for-profit physician organization. A PDF copy of the slides from this program is available for CCRN members of the CCRN website. Visit www.ccrnmd.com/resources to download the materials.